Lauren Barnes
Director/Board Member at ASCELIA PHARMA AB
Network origin in Lauren Barnes first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 24 | |
| Public Company | Pharmaceuticals: Major | 14 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Lauren Barnes via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Private Equity Investor Corporate Officer/Principal | |
| IMMUNOGEN, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
| SANOFI | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
 Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Doctorate Degree | |
| BIOGAIA AB | Pharmaceuticals: Other | Director/Board Member Corporate Officer/Principal | |
Danmarks Eksport- og Investeringsfond
 Danmarks Eksport- og Investeringsfond Investment ManagersFinance Danmarks Eksport- og Investeringsfond (EIFO) is a venture capital subsidiary of Government of Denmark and founded in 1992. The firm is headquartered in Hellerup, Denmark. | Investment Managers | Head-Equity Investments Chief Investment Officer | |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
| Massachusetts Institute of Technology | College/University | Masters Business Admin Doctorate Degree | |
| Indiana University | College/University | Undergraduate Degree | |
| The University of Chicago | College/University | Undergraduate Degree Graduate Degree | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree | |
| Wesleyan University | College/University | Undergraduate Degree Undergraduate Degree | |
| Georgetown University | College/University | Graduate Degree | |
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services American Cancer Society, Inc. provides information on cancer occurrence, survival, prevention, early detection, and treatment. The non-profit company is based in Kennesaw, GA and has subsidiaries in the United States. The company's SHES department is an intramural research program with world-renowned epidemiologists and health scientists. The company was founded in 1913 by Candy Arrington. Karen E. Knudsen has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Lund | College/University | Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
Novartis Institutes for Biomedical Research, Inc.
 Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Sunstone Capital A/S
 Sunstone Capital A/S Investment ManagersFinance Sunstone Capital A/S (Sunstone) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2007 by Peter Benson, Sten Verland, and Søren Lemonius, and invests on behalf of a group of institutional investors. | Investment Managers | Founder Director of Investments | |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Jeka Fish Holding ApS
 Jeka Fish Holding ApS Food DistributorsDistribution Services Jeka Fish Holding ApS operates as a holding company with interest in distribution of seafood products. The company is headquartered in Hørsholm, Denmark | Food Distributors | Chairman | |
| Harvard Business School Health Industry Alumni Association | Corporate Officer/Principal | ||
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| FULCRUM THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Director of Finance/CFO | |
| VOR BIOPHARMA INC. | Biotechnology | Director/Board Member Director/Board Member | |
| KYMERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| CMC SPV of 3 April 2017 AB | Director/Board Member Chairman | ||
| Ascelia Incentive AB | Chairman Director/Board Member Corporate Officer/Principal | ||
Spogárd Invest ApS
 Spogárd Invest ApS Financial ConglomeratesFinance Spogárd Invest ApS is a private company based in Charlottenlund, Denmark. The Danish company provides investment services. | Financial Conglomerates | Corporate Officer/Principal | |
| Spogárd Invest 3 ApS | Corporate Officer/Principal | ||
| APREA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Cimbric AS | Chairman | ||
| Bollerup Jensen Water ApS | Director/Board Member | ||
MOMA Therapeutics, Inc.
 MOMA Therapeutics, Inc. BiotechnologyHealth Technology MOMA Therapeutics, Inc. operates as a biotechnology firm. The company was founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai and is headquartered in Cambridge, MA. | Biotechnology | Chairman | |
| TANGO THERAPEUTICS, INC. | Biotechnology | Chairman Director of Finance/CFO | |
IDRx, Inc.
 IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder Founder | |
Pheon Therapeutics Ltd.
 Pheon Therapeutics Ltd. BiotechnologyHealth Technology Pheon Therapeutics Ltd. is an antibody drug conjugate (ADC) specialist that develops a pipeline of monotherapies for novel targets and/or with novel payloads. The company is based in Harpdenden, UK. The British company's lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types. ADCs offer the potential to treat solid tumors and liquid cancers that have not responded to other treatments. The company was founded in 2015 by Paul Jackson. Cyrus D. Mozayeni has been the CEO of the company since 2023. | Biotechnology | Chairman |
Statistics
International
| United States | 32 |
| Denmark | 8 |
| Sweden | 6 |
| France | 4 |
| Germany | 2 |
Sectoral
| Health Technology | 23 |
| Consumer Services | 11 |
| Commercial Services | 7 |
| Finance | 6 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 144 |
| Corporate Officer/Principal | 82 |
| Independent Dir/Board Member | 52 |
| Chairman | 48 |
| Chief Tech/Sci/R&D Officer | 29 |
Most connected contacts
| Insiders | |
|---|---|
| Peter James Arthur Benson | 58 |
| René Jørgen Spogard | 37 |
| Alexis Borisy | 25 |
| Anna Helena Wennerström | 20 |
| Magnus Olafsson Corfitzen | 17 |
| Mark Goldberg | 17 |
| Lynn Seely | 16 |
| Niels Mengel | 15 |
| Jeffrey Albers | 14 |
| Nicholas B. Lydon | 13 |
| Habib Dable | 11 |
| Kathryn Haviland | 10 |
| John Tsai | 10 |
| Daniella Beckman | 10 |
| Hans Maier | 9 |
- Stock Market
- Insiders
- Lauren Barnes
- Company connections
